2 Groups model FDA [Two-Stage / GS Designs]

posted by hiren379 – India, 2013-08-22 16:32 (3892 d 10:36 ago) – Posting: # 11336
Views: 40,375

Hi HS

❝ Followed by:

❝ If the Group-by-treatment interaction test is not statistically significant (p ≥0.1), only the Group-by-treatment term can be dropped from the model.

❝ … provided that the group meets minimum requirements for a complete bioequivalence study.


According to the above statement, what should be the minimum requirements of the group for a complete bioequivalence study?

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,667 registered users;
74 visitors (1 registered, 73 guests [including 7 identified bots]).
Forum time: 03:08 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5